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Gene-desertThe ventral veinless (vvl) and trachealess (trh) genes are determinants of the Drosophila trachea. Early in
development both genes are independently activated in the tracheal primordia by signals that are ill deﬁned.
Mutants blocking JAK/STAT signaling at any level do not form a tracheal tree suggesting that STAT92E may
be an upstream transcriptional activator of the early trachea determinants. To test this hypothesis we have
searched for STAT92E responsive enhancers activating the expression of vvl and trh in the tracheal primordia.
We show that STAT92E regulated enhancers can be rapidly and efﬁciently isolated by focusing the analysis
on genomic regions with clusters of putative STAT binding sites where at least some of them are
phylogenetically conserved. Detailed analysis of a vvl early tracheal enhancer shows that non-conserved sites
collaborate with conserved sites for enhancer activation. We ﬁnd that STAT92E regulated enhancers can be
located as far 60 kb from the promoters. Our results indicate that vvl and trh are independently activated by
STAT92E which is the most important transcription factor required for trachea speciﬁcation.blo de Olavide, Carretera de
.
 license.© 2010 Elsevier Inc. Open access under CC BY license.Introduction
The JAK/STAT signaling pathway is conserved from vertebrates
to invertebrates (Hou et al., 2002; Levy and Darnell, 2002). STAT
proteins are transcription factors whose misregulation in humans has
been associated to various diseases including cancer. In Drosophila,
JAK/STAT signaling controls diverse developmental processes includ-
ing sex speciﬁcation, segmentation, organogenesis and stem cell
regulation (Arbouzova and Zeidler, 2006; Hombría and Brown, 2002;
Luo and Dearolf, 2001). The identiﬁcation of the direct STAT targets
is of great scientiﬁc and medical relevance as they will help
understanding how STAT controls such varied processes. Drosophila,
with its single STAT protein (STAT92E), offers an excellent model to
study this issue. In mammals the seven STAT proteins preferentially
bind sites containing the palindromic TTCnGAA sequence where n
represents a number of bases from 2 to 4. The different vertebrate
STATs show speciﬁc binding preferences: STAT6mainly binds 4n sites,
while most other STATs bind preferentially 3n sites although STAT3
can also bind 2n sites (Decker et al., 1997; Ehret et al., 2001; Kisseleva
et al., 2002). Drosophila STAT92E shows 3n site binding preference
(Yan et al., 1996). However, in vitro STAT92E also binds 4n sites
with lower afﬁnity and in vivo it can regulate target genes using both
3n and 4n sites (Rivas et al., 2008). Identifying the genes directlyregulated by STAT92E can help to understand the general rules about
how STAT proteins achieve transcriptional speciﬁcity. The expression
of several genes has been reported to be under the regulation of
STAT92E and the number keeps expanding through the use of genetic
and genomic assays. However, only in few cases the regulation has
been proved to be direct by mutating the STAT92E sites either in cell
lines (SOCS36E, Raf) (Baeg et al., 2005; Kwon et al., 2000; Muller et al.,
2005), or in vivo (eve, crb, dome) (Lovegrove et al., 2006; Rivas et al.,
2008; Yan et al., 1996).
The in vivo conﬁrmation that a suspected target is directly regu-
lated by STAT92E is a laborious task requiring the identiﬁcation of the
STAT regulated enhancer in the gene of interest and the molecular
conﬁrmation of the putative STAT sites. In this work, using as a test
case the regulation of the early Drosophila tracheal genes, we explore
how comparative bioinformatics analysis of genomic regions can be
used to rapidly identify STAT regulated enhancers.
The tracheal tree of Drosophila forms a complex reproducible
network of tubes capable of directly delivering oxygen to the animal's
cells. The trachea has been used as a model to study how different
signaling pathways form such stereotypic network. The tracheae
originate from 10 ectodermal placodes present at stage 10 (st10) on
each side of the embryo (Manning and Krasnow, 1993). These clusters
of about 80 to 90 epidermal cells are located in each segment from the
second thoracic (T2) to the eighth abdominal segment (A8). Typically,
each cluster invaginates to form the tracheal pit that then buds six
branches that migrate in different directions. The branches migrating
anteriorly and posteriorly fuse to the equivalent branches of the
adjacent segments creating a continuous dorsal trunk that runs along
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to the spiracles allowing the gas exchange. The remaining branches
target the diverse organs or fuse to other tracheal branches (Manning
and Krasnow, 1993).
Genetic analysis has shown that many signaling pathways are
required to pattern this stereotyped network. Among others the FGF,
EGF, dpp/TGFß, the wg/wnt, Notch, hedgehog and the JAK/STAT
pathways are involved in different aspects of trachea morphogenesis
[reviewed in (Ghabrial et al., 2003)].
Despite much interest on trachea development little is known
about the early tracheal placode speciﬁcation. The earliest sign of
tracheal development is observed at st10 (about 5 h of development
at 25 °C) when thickenings of the dorsal epithelium form the tracheal
placodes. Two genes encoding transcription factors expressed at this
early stage are required for the normal trachea morphogenesis:
trachealess (trh), encoding a bHLH-PAS protein (Isaac and Andrew,
1996; Wilk et al., 1996) and ventral veinless (vvl), encoding a POU-
domain protein (Anderson et al., 1996; de Celis et al., 1995). The vvl
and trh genes are the most upstream genes with tracheal speciﬁc
expression (Fig. 1A,F) and their early activation is independent of each
other (Boube et al., 2000). In trhmutant embryos the tracheal pits do
not form and the tracheal precursors stay on the embryo's surface
(Isaac and Andrew, 1996;Wilk et al., 1996). In vvlmutant embryos the
tracheal pits invaginate but the cells do not branch appropriately
(Anderson et al., 1995; de Celis et al., 1995). The trh and vvl early
tracheal enhancers have not been identiﬁed and it is not yet known
what are the upstream regulators controlling their activation in the
tracheal primordium. Some reports suggest that the JAK/STAT path-
way is the most upstream activator of trh expression in the tracheal
placodes (Brown et al., 2001; Chen et al., 2002). Early vvl tracheal
expression may be modulated by wg, hh and dpp but no direct
molecular evidence has been provided (de Celis et al., 1995). vvl
expression in the hindgut is activated downstream of JAK/STAT
(Brown et al., 2003), but it is not known if vvl is also controlled by JAK/
STAT in the trachea. Finding the vvl cis-regulatory regions is not trivial
as the intergenic region is 144 kb long making it one of the largest in
Drosophila. Here we test if a directed approach focusing on regions
that contain conserved putative STAT92E binding-sites would help
ﬁnding the enhancers without the need to methodically dissect the
whole region. Using this approach we have isolated the vvl hindgut
enhancer and two independent early trachea enhancers all of which
depend on JAK/STAT activity. Molecular analysis of one of the early
tracheal enhancers conﬁrmed that vvl is directly regulated by
STAT92E. Applying the same approach to the trh genomic region we
have uncovered the STAT92E dependent trachea enhancers.We found
that in both vvl and trh the STAT92E regulated enhancers are tens of
kilobases away from the promoter. These results show that a targeted
search of phylogenetically conserved STAT92E sites can be used efﬁ-
ciently to uncover enhancers dependent on STAT regulation in other
genes. Our ﬁndings strongly suggest that the early expression of both
main tracheal transcription factors is regulated directly by STAT92E
underscoring the importance of the JAK/STAT pathway for trachea
speciﬁcation.
Materials and methods
Detection of cis-regulatory elements
We compared the genomic vvl and trh sequences of 10 Drosophila
species including Drosophila melanogaster, D. simulans, D. sechellia,
D. erecta, D. yacuba, D. anannasae, D. grimshawi, D. virilis, D. mojavensis
and D. persimilis. Seven vvl regions containing conserved putative
STAT92E DNA-binding sites were tested for their cis-regulatory
activity. As a control we also chose three regions containing non-
conserved STAT92E sites and two lacking STAT92E binding sites.
Flanking primers (Supplementary Table 1) were used to amplify theD. melanogaster DNA and the fragments were ﬁrst subcloned into
pGEM-T easy (PROMEGA) and then transferred to a pCaSpeR with
lacZ under the control of a minimal promoter (phs43lacZ). Using
the same approach we tested eight trh genomic fragments con-
taining conserved putative STAT92E sites. (For ﬂanking primers see
Sup. Table 2.) Constructs were injected in D. melanogaster by Bestgene
(USA) and the Drosophila Consolider-Ingenio 2007 transformation
platform (Spain). The resulting reporter genes were tested for
expression staining with either anti-ßGal or with a lacZ RNA probe.
For most enhancers at least four independent transgenic lines were
analyzed, with most lines showing consistent patterns of expression
(see Sup. Tables 4 and 5 to ﬁnd the actual number of lines analyzed for
each construct).
Immunohistochemistry and RNA in situ hybridization
Embryos were ﬁxed in 1:1 formaldehyde 4% in PBS/n-heptane for
20 min at room temperature and stained with mouse anti-ßGal to
detect reporter gene expression (PROMEGA). Standard digoxigenin
RNA in situ protocols were performed with lacZ, trh and vvl RNA
probes. For double RNA in situ the vvl probe was labeled with ﬂuo-
rescein RNA labeling mix and the upd probe with DIG RNA labeling
mix (Roche). Embryos were simultaneously hybridized at 55 °C over-
night with both probes. We used anti-Fluorescein-POD (horseradish
peroxidase) to detect the ﬂuorescein labeled probe developing it with
DAB and hydrogen peroxide, and then used anti-DIG-AP to detect the
DIG labeled probe following the standard RNA in situ procedures. For
ﬂuorescent double in situ-antibody stainings embryos carrying the
relevant reporter constructs were hybridized overnight with a vvl
RNA probe. The embryos were incubated 4 h with mouse anti-ßGal
and goat anti-DIG followed by an overnight incubation with anti-ßGal
and anti-goat Alexa647. Finally, on the third day the embryos were
incubated 3 hwith anti-mouse Alexa448 and observed under confocal
microscope.
Mutation of STAT92E DNA-binding sites
Putative STAT92E sites in vvl1+2 were mutated with QuikChange
(Stratagene) using the oligos described in Supplementary Table 3.
Generation of vvl cis-regulatory upstream and downstream deletions
We deleted the vvl upstream cis-regulatory region with the FLP-FRT
technique (Parks et al., 2004) using P[BacWH]f05223, a piggyBac
element inserted 4.5 kb upstream from the vvl transcription start, and
PBac[WH]f01945 that is inserted 74.5 kb upstream. The 70 kb deletion
was conﬁrmedby PCRampliﬁcation. Besides theupstream vvl sequence,
this deﬁciency (named Dfvvl4) removes seven predicted genes.We also
deleted part of the downstream vvl cis-regulatory region using the PBac
[WH]f07247 element, which is inserted 16 kb downstream of the vvl
transcript and PBac[WH]f03756 inserted 174 kb downstream of the vvl
transcription unit. This deﬁciency, namedDf vvl 7247-Mis12, generates a
deletion of about 158 kb affecting 10 predicted genes.
Genetic variants
We used the following null mutant alleles: Df(1)os1A (deﬁcient for
all upd ligands), and the amorphic alleles hopC111 (for JAK), mrl6346
(for stat92E), vvlGA3, vvlH599, trh8, wgCX4. Ectopic upd expression was
induced expressing UAS-upd with the 69B-Gal4 line.
Germ line clones
Null hop embryos were induced in hopC111 FRT101/ovoD1 FRT101;
hs-FLP/+ females by 1 h heatshock at second larval instar. The adult
females were mated to either wild type, vvlds1.5-lacZ, vvl1+2-lacZ or
Fig. 1. vvl expression in wild type and mutant backgrounds. All embryos show vvl RNA in situ expression except (F) that shows trh RNA expression. (A–D) Wild type vvl RNA
expression. (A) At early st10 vvl is transcribed in the primordia of the 10 tracheal pits (black arrowheads in T2 and A8 mark the ﬁrst and last primordia) and in homologous cells in
segments that will not form trachea (white arrowheads). (B) At st11 10 dorsal epithelial patches (black arrow) appear in each trunk segment displaced with respect to the tracheal
primordia (black arrowhead). (C) At st14 epithelial expression has spread to almost all the trunk although certain cells, like some in the posterior spiracles, never express vvl. The
anterior hindgut (white arrowhead) also expresses vvl from st11. (D) At st15 high levels of vvl are expressed in the trachea and in a group of cells migrating dorsally (white arrows in
C and D) that will join the ring gland. (E) vvl RNA in situ in a Dfvvl 7247-Mis12 embryo lacking most of the vvl downstream region showing absence of hindgut expression (white
arrowhead). (F) trh RNA in situ in a wild type st10 embryo showing expression in the salivary gland primordium (asterisk) and in the 10 tracheal pits (black arrowheads mark the
ﬁrst and last pit primordia). (G) Ventro lateral view of a wild type st11 embryo showing vvl expression in the tracheal pit (black arrowhead) and the dorsal patch (arrow). (H) In null
hopmutant embryos at st11 vvl is not expressed in the tracheal pits (arrowhead), while the dorsal patches (arrow) and the midline expression develop normally. (I) Similarly, in null
stat92Emutant embryos vvl is not expressed at st11 in the tracheal pits (arrowhead), while the dorsal patches (arrow) develop normally. (J) Dfvvl4 embryos with deleted upstream
region have no tracheal expression at st10 until at st11 they start developing very weak vvl expression in the tracheal pits (arrowhead). (K) Cartoon depicting the vvl genomic region.
The intronless vvl transcript is located at 27 kb from CG32392 and at 117 kb from Prat2. The orange box represents the 7 kb area analyzed in previous works that uncovered the
autoregulatory RX-drf enhancer. Red arrows mark the position of the early trachea enhancers, green arrow the position of the hindgut enhancer. Blue triangles represent the FRT
piggyBac transposable elements used to delete the upstream and downstream cis-regulatory region (blue lines).
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induced in hsFLP/+; FRT82B mrl6346/FRT82B ovoD L2 females and
mated to FRT82B mrl6346/TM6B males.
Results
The trh gene is expressed and required for the speciﬁcation of the
salivary glands and the tracheal primordia (Fig. 1F, (Isaac and Andrew,1996; Wilk et al., 1996)). The ventral veinless (vvl) gene of Drosophila
is required for the development of several organs including the
trachea, themidline glia, the chordotonal sensory organs and thewing
(Anderson et al., 1995; de Celis et al., 1995; Inbal et al., 2003).
In contrast to the stable trh expression during development, vvl
has a very dynamic pattern (Fig. 1A–D). At stage 9 (st9) and early
st10 expression ﬁrst develops in the tracheal primordia (Fig. 1A)
followed by expression in the midline glial precursors. At st11 dorsal
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tracheal pits (arrows in Fig. 1B,G) and vvl expression appears in the
anterior hindgut (not shown and Fig. 1C). As the embryos mature
at st11 and 12, vvl ectoderm expression broadens up until at st13 it
covers most epidermal cells from T1 to A9 (Fig. 1C). A few cells in the
trunk remain void of vvl including some sensory organs in every
segment and some cells in the anterior and posterior spiracles. At st14
the oenocytes (not shown) and a group of cells that will integrate into
the ring gland show increased levels of vvl expression (arrows in
Fig. 1C–D).
vvl expression in the trachea and hindgut primordia depends on JAK/
STAT function
Past work has shown that the JAK/STAT pathway is the earliest
activator of trh in the tracheal primordia (Brown et al., 2001) but
nothing is known about how the vvl early trachea expression is
activated. As STAT92E is required for trh activation, and trh is neces-
sary to maintain vvl expression from st11, a direct requirement of the
JAK/STAT pathway for vvl tracheal activation is difﬁcult to ascertain.
To ﬁnd out if JAK/STAT is required for early vvl activation, we carefully
analyzed vvl expression in germ line mutants lacking either JAK or
STAT92E before the Trh/Vvl cross-regulatory interactions start. We
observe that in stat92E and hop germ line clone embryos (completely
lacking STAT and JAK function respectively, see Materials and
methods) vvl is not expressed in the tracheal placodes at st10 and
early st11 (compare Fig. 1G and H–I), suggesting that vvl is also
directly activated by STAT92E in the trachea. As previously reported
(Brown et al., 2003), we also observed that the vvl expression in the
hindgut requires JAK/STAT signaling.
vvl is an intronless gene located in a 144 kb “gene-desert” region
with the closest neighboring genes located 27 kb upstream and
117 kb downstream (Fig. 1K). In this large region only the immediate
upstream 7 kb of vvl cis-regulatory DNA have been studied (Fig. 1K
orange box) leading to the discovery of the autoregulatory RX-drf
enhancer that becomes active at late st11 in the trachea, the oenocytes
and the midline glia (Certel et al., 1996) (drf is a synonym for vvl).
RX-drf expression is completely dependent on the endogenous Vvl
protein expression (Certel et al., 1996; Zelzer and Shilo, 2000).
Besides this autoregulatory module, no other tissue speciﬁc enhan-
cers have been described in this vast intergenic region. To help
localizing the vvl enhancers we generated deletions of the vvl
upstream and downstream regions using the FLP-FRT technique (see
Materials and methods). Embryos homozygous for the Dfvvl4
upstream deletion (Figs. 1K and 2A) lack early st10 vvl expression
in the tracheal pits, with vvl only appearing in the trachea at late st11
(Fig. 1J compare with G). These embryos form an aberrant tracheal
tree that, as is the case in vvl null mutants, does not fuse in a longi-
tudinal dorsal trunk (not shown). vvl expression in the ectoderm,
hindgut, st11 dorsal ectodermpatches andmidline glia is not affected
in Dfvvl4 (Fig. 1J and not shown) indicating that these enhancers lie
downstream or are redundant localizing both in downstream and
upstream regions. In contrast, embryos homozygous for the down-
stream deletion Dfvvl7247-Mis12 (Figs. 1K and 3A) do not affect the
trachea but lack hindgut expression (Fig. 1E).
Search for STAT-regulated vvl enhancers
If vvl expressionwas controlled directly by STAT92E, the enhancers
should contain STAT92E binding sites that would facilitate their
location. We searched in the vvl genomic region for 3n (TTCnnnGAA)
and 4n (TTCnnnnGAA) sequences that have been shown to be
regulated by STAT92E in vivo (Rivas et al., 2008; Yan et al., 1996).
These sequences are present at 85 places in the vvl D. melanogaster
intergenic region (vertical stripes in Figs. 2A and 3A), 20 of which are
conserved in the vvl genomic region of several Drosophilids (markedwith an asterisk). We made 10 reporter genes containing the putative
STAT92E sites and, as control, two lacking them testing their ability to
express lacZ in D. melanogaster embryos (Sup. Table 4). Our analysis
uncovered several embryonic enhancers upstream (Fig. 2B–G) and
downstream (ds) (Fig. 3B–F) the vvl transcription unit. Among them
two independent early (st10) trachea enhancers (Fig. 2B–C), and a
hindgut enhancer active fromst11 (Fig. 3E–F).We also identiﬁed other
enhancers driving expression in sensory organs, ectoderm, late
trachea (st13), posterior spiracles and oenocytes (Figs. 2 and 3 and
Sup. Table 4). To conﬁrm that the enhancers are expressed in the vvl
pattern, we performed ﬂuorescent vvl RNA in situ and ß-Gal double
staining (Sup. Fig. 2). The ß-Gal expression in vvl9 and vvl1.0 was too
weak and did not produce good double stainings. All other constructs,
with the exception of the posterior spiracle enhancer, drive ß-Gal
expression in vvl expressing cells.
As a rapid test for the requirement for JAK/STAT regulation, we
analyzed the expression of these enhancers in Dfos1A embryos.
This deﬁciency deletes upd, upd2 and upd3 that encode all Drosophila
JAK/STAT ligands (Hombría et al., 2005). This showed that the early
trachea and the hindgut enhancers require JAK/STAT function
(Figs. 2H–I and 3K). Expression of vvlds1.7 in the posterior spiracle
is also lower in Dfos1A embryos than in wild type (Fig. 3C,I), however
we believe this effect may be indirect as vvlds1.7 is activated at st14
after upd transcription has stopped in the spiracle and there is no
nuclear STAT92E in the posterior spiracle cells (Sotillos et al., 2008)
and in any case this enhancer does not normally activate vvl tran-
scription. In some cases a requirement of STAT92E to regulate the
enhancers could not be ascertained due to the strong morphological
defects caused by the absence of JAK/STAT function. For example, in
Dfos1A embryos where the tracheal tree does not form, the absence of
vvl6 expression in the cells associated to the trachea could be an
indirect effect due to the absence of trachea. Therefore, although we
cannot discard these enhancers are regulated directly by STAT92E we
will not consider them any longer.
STAT92E regulation of the vvl hindgut enhancer
The vvlds1.5 enhancer is among the fragments with more con-
served putative STAT92E sites. vvl transcription in the anterior hindgut
has been proposed to be under JAK/STAT regulation (Brown et al.,
2003). The vvlds1.5 enhancer correctly reports the vvl activation
(Fig. 3E–F), however while vvl transcription in the hindgut stops
at st15; lacZ in situ hybridization in vvlds1.5 shows that this reporter is
transcriptionally active up to st17 (not shown). Despite this anoma-
lous behavior, the enhancer's regulation up to st15 mimics that
described for the endogenous vvl transcription (Brown et al., 2003),
with lack of Upd or JAK kinase resulting in lack of hindgut activation
(Fig. 3K–M); and ectopic upd overexpression with 69B-Gal4 inducing
vvlds1.5 ectopic expression in the posterior hindgut (Fig. 3G). These
data indicate a correlation between the accumulation of conserved
putative STAT92E sites and the presence of enhancers whose
expression depends on JAK/STAT activity.
STAT92E regulation of early vvl trachea enhancers
To conﬁrm that JAK/STAT regulates early vvl tracheal expression
we further analyzed the vvl1+2 and vvl345 trachea primordia en-
hancers. Analysis of the expression of both early enhancers by lacZ in
situ shows that they drive expression very transiently at st10–st11
(Fig. 4A–B,H–I). The vvl1+2 fragment drives lacZ expression in the
tracheal placodes and in smaller spots in homologous regions of
segments not forming trachea (Fig. 2B arrowheads). This pattern
resembles the expression of vvl at st10 (Fig. 1A and de Celis et al.,
1995). The three anterior spots correspond to the maxillary, labial and
ﬁrst thoracic segments while the two posterior spots correspond to
the abdominal 9 and 10 segments (A9–A10). The vvl345 fragment also
Fig. 2. Upstream vvl embryonic enhancers in wild type and upd mutant background. (A) Cartoon showing the location of the upstream vvl enhancers analyzed. Vertical
lines represent putative STAT92E binding sites. An asterisk marks sites conserved in all 10 studied Drosophilids. Orange line represents the upstream region analyzed previously
(Certel et al., 1996). Red lines represent the early tracheal enhancers. Green line represents the oenocyte enhancer. Horizontal blue line indicates the deleted upstream region in
Dfvvl4. (B–G) Expression of the indicated enhancers in wild type embryos. (H–M) Expression of the same enhancers in Dfos1A embryos lacking all three upd ligands. Note the strong
effect that lack of upd has on vvl1+2 and vvl345 expression (H–I). Black arrowheads point to the tracheal pits, white arrowheads point to the homologous patches in anterior and
posterior segments.
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main difference with the vvl1+2 fragment expression being that the
small spots anterior and posterior to the tracheal pits are not labeled
prominently.
To deﬁne at what level of the trachea morphogenetic cascade
the vvl1+2 and vvl345 enhancers are acting, we studied if their
expression is affected in mutants for vvl and trh, the earliest known
tracheal speciﬁc genes (reviewed in Ghabrial et al., 2003). In vvl
mutant embryos neither construct was affected (Fig. 4D,K) and wecould observe that the labeled cells invaginated but were unable to
form a normal tracheal network. These results prove that vvl1+2 and
vvl345 are not autoregulatory enhancers.
As the maintenance of vvl expression in the trachea also requires
Trh function (Boube et al., 2000; Zelzer and Shilo, 2000) we tested the
expression of vvl1+2 and vvl345 in trh mutants. Both enhancers are
activated normally in trhmutant embryos but the labeled cells do not
invaginate, remaining on the surface of the embryo (Fig. 4E,L). To
discard a redundant function of trh and vvl on the activation of the
Fig. 3. Downstream vvl embryonic enhancers in wild type and updmutant backgrounds. (A) Cartoon representing the location of the downstream vvl enhancers analyzed. Symbols
are as in Fig. 2. (B–F) Expression of the indicated enhancers in wild type embryos. (H–L) Expression of the same enhancers in a Dfos1A embryos lacking all three upd ligands. (K–L)
Note the strong effect that lack of upd has on vvlds1.5 hindgut expression. (G) Ectopic upd results in ectopic vvlds1.5 expression in the most posterior area of the hindgut (small
arrowheads) and in the salivary glands. (M) In null hop mutant embryos vvlds1.5 is not expressed in the hindgut (arrowhead).
576 S. Sotillos et al. / Developmental Biology 340 (2010) 571–582early trachea enhancers we also studied their expression in trh,
vvl double mutant embryos and observed that even in this condi-
tion vvl1+2-lacZ and vvl345-lacZ are still expressed (not shown).
The above results indicate that the early vvl trachea enhancers are
controlled by the exogenous cues that deﬁne the early tracheal
speciﬁcation.
The WNT pathway has been suggested to be one such exogenous
cue. Wg is expressed in every segment along a dorso-ventral stripe of
cells running between the tracheal pits. Inactivation of the WNT
pathway results in ectopic vvl expression in the areas between pits
indicating that the pathway represses vvl transcription (de Celis et al.,
1995). In wg null mutants, we observed ectopic expression of both
vvl1+2 and vvl345 (Fig. 4F,M) indicating that vvl repression betweenpits may be mediated through these enhancers. As it also happens
with the vvl RNA, the levels of expression in the tracheal pits are still
higher than between pits suggesting that other negative elements
besides the WNT pathway are modulating the expression.
As shown above the early vvl trachea enhancers are not expressed
in Df(1)os1A embryos (Fig. 2H–I) suggesting that the JAK/STAT
pathway is the positive exogenous cue activating vvl. However, as this
mutation deletes other genes beside the upd ligands we conﬁrmed the
JAK/STAT dependence removing the JAK kinase by generating null
hopC111 germ line clones embryos (Binari and Perrimon, 1994;
Perrimon and Mahowald, 1986). As expected neither enhancer was
expressed in hopC111 embryos lacking the maternal and zygotic hop
gene (Fig. 4G,N).
Fig. 4. Expression of early vvl tracheal enhancers in variousmutant backgrounds. (A–G) vvl1+2 expression and (H–N) vvl345 expression. (A) lacZRNA in situ of awild type vvl1+2 st10
embryo showing the expression in the tracheal primordia (black arrowheads point the primordia in T2 and in A8) and in the anterior and posterior spots that will not form trachea
(white arrowheads). (B) lacZ RNA in situ of a vvl1+2 st15 embryo showing the enhancer is not expressed at later stages. (C) ß-Gal expression of a vvl1+2 st15wild type embryo. Note
that long-lived ß-Gal perduring expression can be still detected in the trachea and in a group of cells moving dorsally (Arrows). (D) In vvl mutants vvl1+2 is activated but the
expressing cells do not form normal trachea. (E) In trhmutant embryos ß-Gal expressing cells do not invaginate staying on the embryo's epidermal surface. (F) Inwgmutant embryos
vvl1+2 expression is not restricted to the tracheal primordia. Note that levels of expression are still lower outside the normal pit position. (G) vvl1+2 expression is almost missing in
hopmutants lackingmaternal and zygotic JAK. (H) lacZ RNA in situ of a vvl345 st10 embryo showing the expression in the tracheal primordia (black arrowheads point the primordia in
T2 and in A8). The expression in the homologous spots in anterior segments is veryweak (white arrowheads). (I) lacZ RNA in situ of a vvl345 st15 embryo showing that the enhancer is
not expressed any longer. (J) ß-Gal expression of a vvl345 st15 embryo. The perduring protein can be detected by the antibody. (K) In vvl mutants vvl345 is activated but the
invaginated cells do not fuse into a tracheal tree. (L) In trhmutants vvl345 is expressed but the cells remain on the embryonic epidermis. (M) Inwgmutants vvl345 expression is not
restricted to the tracheal pits. (N) vvl345 expression is almost missing in hopmutants lacking maternal and zygotic JAK. (A–B, H–I) show lacZ RNA in situ. (C–G, J–N) show anti-ßGal.
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STAT92E binding sites
STAT92E mutants blocking the JAK/STAT pathway at any level of
the signaling cascade do not form a tracheal tree, a phenotype that
previously has been explained by their abnormal trh expression
(Brown et al., 2001). However, the results here presented indicate
that vvl is also regulated directly by the JAK/STAT pathway.
To conﬁrm that the early tracheal enhancers are regulated
through the putative STAT92E DNA-binding sites, we have analyzedthe vvl1+2 fragment that reﬂects the early vvl expression. Com-
parison of this 680 bp DNA fragment between several species of
Drosophilidae (Stark et al., 2007) showed 10 conserved sequence
blocks in the distal two thirds of the element (Fig. 5A and
Sup. Fig. 1). Of the three putative STAT92E binding sites [TTCnnn
(n)GAA] in the vvl1+2 fragment two of them, a 3n and a 4n site, are
conserved in all species while a further 3n site is only present in
D. melanogaster.
We tested the effect of mutating some combinations of the puta-
tive STAT92E binding sites in the vvl1+2 enhancer. Single mutation
Fig. 5. Expression of the vvl1+2 early tracheal enhancers is controlled by STAT92E signaling. (A) Scheme of vvl1+2 and subfragments tested. Black boxes represent blocks of
conserved sequence in all 10 Drosophila species analyzed (see supplementary Fig.1 for sequence). Red rectangles represent the location of the three putative STAT92E DNA-binding
sites. Only two of the sites are located in conserved blocks while the third one is only present inD. melanogaster. (B)Wild type vvl 1+2 expression at st10. (C) ß-Gal expression driven
from a vvl 1+2 construct where the two conserved putative STAT92E binding sites have been mutated. Expression is lower than in the wild type, especially anterior to the second
abdominal segment, but substantial levels of expression remain. (D) ß-Gal expression driven from a vvl 1+2 construct with all three putative STAT92E binding sites mutated.
Expression is highly reduced but traces still remain. (G) The vvl1+2MiniS1 fragment does not drive tracheal expression. (H) vvl MiniS2 drives tracheal expression in embryos at st11.
The expression seems to be less restricted with some ectopic signal between the pits. (I) The vvl1+2 MiniS3 fragment does not drive tracheal expression. (E, J) A wild type st10
embryo double stained to show the upd RNA expression (purple) and the vvl RNA expression (brown). (J) is a magniﬁcation of E that has been rotated 180 degrees to have dorsal up
and anterior left. Note the continuous upd stripe (purple arrows) running along the antero-posterior axis of the embryo just ventral to the vvl tracheal expression. (F) Scheme of the
embryo shown in E that has been rotated 180° like panel J to have dorsal up and anterior left in the region of interest. Besides the tracheal pits and upd expression the scheme shows
the location of the wg expressing cell stripes. (K) Scheme of proposed negative and positive regulation of early enhancers in the tracheal placodes. (B–D, G–I) Embryos are stained
with anti-ßGal antibody. (E, J) show upd RNA in purple and vvl RNA in brown.
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tracheal expression signiﬁcantly (not shown). Surprisingly, simulta-
neous mutation of the two conserved STAT92E sites at positions 86
and 219 only resulted in a mild decrease of the tracheal pit expression
that is more noticeable in the segments with lower levels of expres-
sion (Fig. 5C). Mutation of all three sites reduces the expression from
all segments (Fig. 5D).Subdivision of the vvl1+2 element into three subfragments each
containing a STAT92E site (Fig. 5A) shows that the two ﬂanking
fragments (vvl1+2MiniS1 and vvl1+2MiniS3) cannot activate tracheal
expression (Fig. 5G,I). In contrast, the central fragment (vvl1+
2MiniS2) can drive tracheal expression although its spatial restriction
is less deﬁned with some embryos showing ectopic expression be-
tween the pits suggesting the loss of some repressor-binding site in the
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vvl1+2MiniS3 fragment is dispensable and cannot drive tracheal
expression by itself. However, in the context of vvl1+2, when the
conserved STAT92E sites are mutant, the non-conserved site at posi-
tion 508 can contribute to enhancer activation. Thus a non-conserved
site in a STAT92E site cluster can contribute to the enhancer's
expression probably by interacting with other proteins binding to
the enhancer core (vvl1+2MiniS2) that provide the tracheal activa-
tion speciﬁcity.
As we have seen, in wgmutant embryos, vvl and the early tracheal
enhancers are expressed in a continuous band of cells running along
the antero-posterior axis (Fig. 4F,M). These results indicate that the
most upstream activator of vvlmust be capable of activating vvl in the
areas between the tracheal pits. Both upd and upd2 are expressed in
the tracheal pits at st11 (Harrison et al., 1998; Hombría et al., 2005)
but the expression of updwith respect to the trachea primordia before
the deﬁnition of the tracheal pits has not been analyzed carefully.
Double RNA in situ of upd and vvl shows that the earliest activation of
vvl occurs when upd is transiently expressed in a stripe that runs along
the antero-posterior axis of the embryo just ventral to the tracheal
placodes (Fig. 5E,J). Thus the pattern of expression of upd is consistent
with that expected for the vvl trachea activator.
Search of STAT92E regulatory elements in trh
Our results suggest that a targeted phylogenetic approach could
be used to ﬁnd STAT92E regulated enhancers. To prove the case for
other putative STAT92E targets we tested if a similar approach could
help ﬁnding the early trh trachea enhancers. We ﬁrst analyzed
the approximately 25 kb comprised between CG13884 and CG13885Fig. 6. trh embryonic enhancers in wild type andmutant backgrounds. (A) Cartoon represent
binding sites. An asterisk marks sites conserved in all Drosophilids. Black boxes represent th
the trh cis-regulatory region. (B–D) Expression of three early trh tracheal enhancers in a wild
(B–D). Most expression disappears from trh66 and trh67while substantial signal is still prese
driven by trh24, there is also some expression in the pharyngeal ectoderm (asterisk). (I) Exp
background. Lateral views with head left dorsal up in all embryos except H that shows a frincluding the trh introns (Fig. 6A). In this area there are only two
regions with conserved putative sites one of which, trh24, drives
expression in the anterior and posterior spiracles of the embryo
and the other, trh31, is not expressed (Fig. 6H, and not shown). We
observed that further upstream of trh, distal to CG13885, there is a
gene-desert region of 40 kb with a high number of putative STAT92E
sites. Given the precedent of the distal location of the trachea vvl
elements wewondered if the trachea enhancers could locate here.We
tested six fragments containing the conserved STAT92E sites and
found that while the most distal two fragments, trh75 and trh79, are
silent the other four are expressed at different stages of trachea
development. trh47 and trh66 are expressed in the trachea from st10,
trh67 from st11 and trh45 from st13 (Fig. 6B–D and I). Of the three
early trachea enhancers, RNA in situ with lacZ probes reveals that
trh47 and trh66 are transiently expressed from st10 to st11 while
trh67 expression lasts up to st15 (not shown). To ﬁnd at what level
of the trachea cascade the three early enhancers are regulated we
analyzed their expression in Dfos1A, vvl, trh and vvl trh double
mutants. The expression of all three early enhancers is affected to
different degrees in Dfos1A mutant embryos (Fig. 6E–G) and are
ectopically expressed in wg mutants (Fig. 6J and not shown).
Expression of the early enhancers does not require vvl (compare
Fig. 7A–C with D–F). Only the expression of the trh67 st11 enhancer is
affected in trh and in the double trh, vvl mutants (Fig. 7G–L).
Therefore, our results indicate that the trh67 st11 enhancer is auto-
regulatory, while the st10 elements depend on upstream extrinsic
tracheal signals. While the effect of the lack of upd ligands on trh67
could be indirect due to the abnormal activation of trh in Dfos1A
embryos, the effect on trh66 may be direct. Surprisingly, the
expression of trh47 is not very abnormal (Fig. 6E) leaving open theing the location of the trh enhancers analyzed. Vertical lines represent putative STAT92E
e analyzed regions. Arrows indicate transcribed regions. Note that CG13885 nests inside
type background. (E–G) Expression in Dfos1A embryos of the same enhancers shown in
nt in trh47. (H) Posterior (white arrow) and anterior spiracle (black arrows) expression
ression of the trh45 late trachea enhancer. (J) Expression of trh67 in a winglessmutant
ontal section.
Fig. 7. Expression of early trh tracheal enhancers in various mutants. (A–C) ß-Gal expression of the early enhancers at st13, all lines delineate the internalized tracheal network.
(D–F) Expression of the early trh trachea enhancers is not affected in homozygous vvlmutant embryos despite the aberrant migration of the tracheal cells. (G–H) Expression of
the trh47 and trh66 is maintained in trhmutant embryos with the uninvaginated ectodermal cells remaining on the embryo surface. (I) Expression of the trh67 enhancer requires
trh function suggesting a strong degree of autoregulation. (J–L) Expression of trh47 and trh66 in double vvl trhmutant embryos is maintained, while trh67 is absent. Embryos in
panels A–I are homozygous for the reporter constructs while in panels J–L are heterozygous.
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activator.
Thus, by exclusively analyzing the conserved STAT92E sites in the
trh genomic region we were able to uncover the early STAT92E
regulated enhancers. It is interesting to note that there are conserved
STAT92E sites associated to late tracheal enhancers. Upd expression is
maintained on the trachea during most of embryogenesis (Harrison
et al., 1998). The association of conserved STAT92E sites to the later
enhancers suggests that Upd may also contribute to maintain trh
expression in the trachea through these elements, however the pre-
vious requirement of STAT92E for early vvl and trh activation and the
effects these have on trachea development do not allow reaching any
conclusions on this respect. Taken together, these results conﬁrm that
a phylogenetically targeted approach is an efﬁcient method to isolate
the STAT92E regulated enhancers.Discussion
Mutations in STAT proteins are linked to disease in humans and
in Drosophila they affect the development of several major organs,
embryo segmentation and maintenance of gonad and gut stem cells.
Finding the direct targets of STAT holds the key to understanding how
such different functions are controlled. Microarray techniques can be
used to analyze at the genome level genes that are up- or down-
regulated by STAT while ChIP-chip analysis can identify DNA regions
directly bound by STAT uncovering hundreds of possible targets.
However, as the transcriptional up- or down-regulation detected in
microarrays could be indirect, and STAT92E binds chromatin without
necessarily resulting in transcriptional regulation (Shi et al., 2008),
these results have to be validated by time-consuming in vivo experi-
ments. In this work we show that analysis of STAT92E conserved sitesprovides a rapid way to isolate STAT92E regulated enhancers even in
large cis-regulatory regions.
Direct analysis of phylogenetically conserved STAT92E sites successfully
uncovers JAK/STAT regulated enhancers
Mutations in the JAK/STAT pathway result in embryos only
forming residual trachea fragments. This is caused by the abnormal
activation of the early tracheal genes trh and vvl (this work and Brown
et al., 2001; Chen et al., 2002) suggesting that the early trachea
enhancers may be directly regulated by STAT92E in which case the
trachea enhancers would be associated to STAT92E binding sites.
To test this we ﬁrst localized in silico the putative STAT92E
binding sites in the vvl 144 kb intergenic region (Rivas et al., 2008;
Yan et al., 1996). We then compared in vivo the enhancer activity of
regions that either (1) contain putative STAT92E sites that are
conserved in several Drosophila species; (2) contain non-conserved
putative STAT92E sites; or (3) contain no putative STAT92E sites. Of
the 12 reporter lines made 10 have enhancer activity consistent with
harboring embryonic vvl cis-regulatory elements. The expression of
the enhancers either lacking STAT92E sites or containing non-
conserved STAT92E sites is independent of JAK/STAT function. In
contrast, of the seven vvl enhancers containing conserved sites, the
expression of three of them required JAK/STAT regulation in the
embryo. One of these enhancers drives expression in the hindgut and
two are expressed in the trachea at st10. These results suggested that
exclusively looking for conserved STAT92E sites would be sufﬁcient
to localize the STAT92E regulated sites, a prediction we have
conﬁrmed by isolating the trh gene tracheal enhancers. Although
we cannot discard the presence of cryptic STAT binding sites that
diverge from the ideal consensus we used in our analysis, such
elements will probably have a minor contribution as ignoring their
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of only eight fragments comprising a seventh of the trh locus was
sufﬁcient to ﬁnd the early tracheal STAT92E responsive elements.
This analysis uncovered that the locus extends at least 40 kb up-
stream the trh promoter, with some enhancers located beyond the
ﬁrst predicted neighboring gene.
In both the trh and vvl genes we found that other late tracheal
enhancers are associated to STAT92E conserved sites suggesting that
the STAT92E protein may be repeatedly used to control tracheal gene
expression during development. This possibility is backed by the fact
that upd is transcribed up to st13 and phosphorylated STAT92E can be
detected in the trachea well after the st10 early speciﬁcation stage
(Harrison et al., 1998; Li et al., 2003). This late trachea speciﬁc
expression of upd depends on trh (Bridget Lovegrove and JC-GH
unpublished) suggesting that a feed-back loop maintains JAK/STAT
activity during tracheal development.
We conﬁrmed that the expression of the vvl1+2 early tracheal
enhancer depends on STAT92E by mutating its putative STAT92E
binding sites. Our results show that mutation of all three putative
STAT92E sites in the vvl1+2 enhancer causes a severe loss of
expression, indicating that we isolated a bona-ﬁde direct enhancer.
However, other possible direct enhancers like the vvlds1.5 hindgut
element show an unexpected behavior. While vvlds1.5 perfectly
recapitulates the vvl early hindgut activation its expression does not
stop at st15, but keeps transcribing lacZ up to st17 well after the
endogenous vvl gut transcription ceased. Despite this abnormal
behavior, and pending direct site mutagenesis conﬁrmation, we
believe that our experiments show convincingly that the analysis of
the genomic regions containing conserved STAT binding site clusters
is an efﬁcient way to quickly identify direct STAT92E regulated
enhancers.
An important ﬁnding of our analysis has been the observation that
STAT regulated enhancers can be tens of kilobases away from the
transcriptional start of the target gene, even separated by another
predicted gene. This indicates that STAT regulated enhancers can be
functional at great distances and that search of STAT binding sites
should not be restricted to the immediate vicinity of a gene.
Conserved STAT92E site clustering
Assuming therewas no base content bias, the probability of ﬁnding
in the genome either a 3n or a 4n STAT92E site by chance is (2×1/46)
which is close to one site every 2 kb. In the 144 kb vvl genomic region
there are 85 putative STAT92E sites, that is, 15more than the expected
70 sites. Similarly, in the 70 kb trh locus there are 53 putative sites, 19
more than the expected 34 sites. The excess of sites found can be
partially explained by selective pressure as there are 20 conserved
sites in vvl. However, in the trh locus the 9 conserved STAT92E sites
represent only half of the observed excess. An additional explanation
for the excess STAT92E sites could be provided by the observation that
in the regions were we found evidence for JAK/STAT regulation, there
are clusters of conserved and non-conserved sites. It has been sug-
gested that STAT site clustering helps forming tetramers that co-
operatively increase STAT transcriptional output (Bergad et al., 1995;
Ota et al., 2004; Xu et al., 1996). Although STAT92E may form similar
tetrameres in Drosophila, the distance of the clustered sites we
observe here is probably too large to allow tetramer formation and
their existence must serve another purpose. When we subdivide the
vvl1+2 enhancer we observe that the distal non-conserved STAT92E
site is dispensable for the enhancer function (compare Fig. 5H and I).
However mutagenesis of the two conserved sites in vvl1+2 without
mutating the distal non-conserved site has a mild decrease in the
enhancer expression (Fig. 5C). Only when we mutate all three sites,
including the non-conserved site, there is a strong effect on vvl1+2
expression (Fig. 5D). This shows that non-conserved sites may be
functional in vivo even though they are not absolutely necessary. Ourresults indicate that sites appearing distal to a STAT92E regulated
enhancer may substitute for the proximal conserved sites, suggesting
a way in which novel functional sites could eventually substitute
conserved sites during evolution.
The crb and dome genes, which have been shown in vivo to be
STAT92E targets (Lovegrove et al., 2006; Rivas et al., 2008), also show
an accumulation of STAT92E sites in the introns where the enhancers
localize. In the case of dome, ﬁve STAT92E sites cluster in a 700 bp
fragment. Although only two of the ﬁve sites are conserved, and
dissection of the enhancer showed that the conserved sites are crucial
for JAK/STAT regulation, the non-conserved sites were also required
for full enhancer expression (Rivas et al., 2008). Therefore, clustered
conserved and non-conserved STAT92E sites contribute to target gene
regulation. It will be important to understand how STAT92E proteins
binding to these distant sites interact with other transcriptional co-
factors that presumably bind to the core enhancer.
STAT92E and the evolution of arthropod respiratory system
The earliest genes activated speciﬁcally in the tracheal primordia
are trh and vvl. Both genes have cross-regulatory interactions that
help maintain each other's expression in the trachea, but their early
activation is independent of each other. Here we have localized the
early trachea enhancers in trh and vvl and have shown that their
activation in both cases depends on the JAK/STAT pathway making
STAT92E the most important trachea activator. St10 upd expression
is consistent with a model where trh and vvl activation in the tra-
cheae primordia is speciﬁed by a competitive interaction between the
JAK/STAT and the WNT signaling pathways. STAT92E is probably
acting with some other transcription factor(s) as inactivation of the
JAK/STAT pathway does not result in a complete lack of expression of
the enhancers (Figs. 2H–I and 6E-G). These other transcription factors
would not necessarily have a restricted spatial expression as the
precise positional activation of vvl could be provided by upd and wg.
Although the early requirement of STAT92E for early tracheal speci-
ﬁcation precludes any studies at later stages, the maintained expres-
sion of upd in later tracheal development and the presence of STAT92E
conserved sites associated to late tracheal enhancers suggest that the
pathway is important for vvl and trh expression maintenance during
tracheal development.
The observation that in crustaceans trh and vvl are co-expressed in
the epipods that form the gills suggest that both genes where co-
opted early in arthropod evolution to control the formation of the
respiratory system (Franch-Marro et al., 2006). It would be interesting
to ﬁnd out if JAK/STAT is also required for trh and vvl expression in the
crustaceans as that would suggest that the pathway had been adopted
early in evolution ﬁxing the regulation of both genes in the respiratory
system.
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